Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ETHANOL (ANHYDROUS) - REFERENCE SPECTRUM (N/A)

ETHANOL (ANHYDROUS) - REFERENCE SPECTRUM (N/A)

ND

DISCOVER
LACTOSE (ANHYDROUS) CRS (30 MG)

LACTOSE (ANHYDROUS) CRS (30 MG)

ND

DISCOVER
Acebutolol D7

Acebutolol D7

2701782-36-5

DISCOVER
ANTAZOLINE HYDROCHLORIDE CRS (50 MG)

ANTAZOLINE HYDROCHLORIDE CRS (50 MG)

2508-72-7

DISCOVER
ALFADEX CRS (160 MG)

ALFADEX CRS (160 MG)

10016-20-3

DISCOVER
APROTININ SOLUTION BRP (0.5 ML)

APROTININ SOLUTION BRP (0.5 ML)

9087-70-1

DISCOVER
L-ARABINITOL CRS (10 MG)

L-ARABINITOL CRS (10 MG)

7643-75-6

DISCOVER
ARGININE CRS (60 MG)

ARGININE CRS (60 MG)

74-79-3

DISCOVER
ARGININE HYDROCHLORIDE CRS (60 MG)

ARGININE HYDROCHLORIDE CRS (60 MG)

1119-34-2

DISCOVER
ASCORBIC ACID CRS (70 MG)

ASCORBIC ACID CRS (70 MG)

50-81-7

DISCOVER
ASPARTAME CRS (40 MG)

ASPARTAME CRS (40 MG)

22839-47-0

DISCOVER
ASPARTAME IMPURITY A CRS (20 MG)

ASPARTAME IMPURITY A CRS (20 MG)

02/10/5262

DISCOVER